Literature DB >> 2065051

Characterization of the R-state insulin hexamer and its derivatives. The hexamer is stabilized by heterotropic ligand binding interactions.

M L Brader1, N C Kaarsholm, R W Lee, M F Dunn.   

Abstract

1H NMR and UV-visible electronic absorption studies have been performed to investigate the effects of anions and cyclic organic molecules on the interconversion of the T- and R-conformational states (Kaarsholm et al., 1989) of hexameric M (II)-substituted insulin in solution (M = Zn or Co.). Two ligand binding processes that stabilize the R-state conformation of the M(II)-substituted insulin hexamer [M(II)-R6] have been distinguished: (i) The binding of neutral organic molecules to the six, crystallographically identified, protein pockets in the Zn(II)-R6 insulin hexamer (Derewenda et al. 1989) generate homotropic site-site interactions that stabilize the R-state. Cyclohexanol, phenol, 4-nitrophenol, and 4-hydroxymethylbenzoate are shown to bind at these sites. (ii) The coordination of singly charged anions that are able to gain access to the two HisB10 coordinated metal ions of the M(II)-R6 hexamer stabilizes the R-state. Adducts of the M(II)-R6 hexamer are formed, thereby, in which the solvent-accessible fourth coordination position of the M(II) ion is replaced by a competing anion. Binding to these two classes of sites introduces strong heterotropic interactions that stabilize the R-state. UV-visible spectral data and apparent affinity constants for the adducts formed by the Co(II)-R6 hexamer with a wide range of anionic ligands are presented. The Co(II)-R6 adducts have a strong preference for the formation of pseudotetrahedral Co(II) centers. The HCO3- and pyridine-2-thiolate ions form Co(II)-R6 adducts that are proposed to possess pentacoordinate Co(II) geometries. The relevance of the Co(II)-R6 complexes to carbonic anhydrase catalysis and zinc enzyme model systems is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2065051     DOI: 10.1021/bi00241a002

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Unraveling the symmetry ambiguity in a hexamer: calculation of the R6 human insulin structure.

Authors:  S I O'Donoghue; X Chang; R Abseher; M Nilges; J J Led
Journal:  J Biomol NMR       Date:  2000-02       Impact factor: 2.835

2.  Insulin analogs for the treatment of diabetes mellitus: therapeutic applications of protein engineering.

Authors:  Daniel F Berenson; Allison R Weiss; Zhu-Li Wan; Michael A Weiss
Journal:  Ann N Y Acad Sci       Date:  2012-03-13       Impact factor: 5.691

3.  Non-equivalent role of inter- and intramolecular hydrogen bonds in the insulin dimer interface.

Authors:  Emília Antolíková; Lenka Žáková; Johan P Turkenburg; Christopher J Watson; Ivona Hančlová; Miloslav Šanda; Alan Cooper; Tomáš Kraus; A Marek Brzozowski; Jiří Jiráček
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

4.  Physicochemical basis for the rapid time-action of LysB28ProB29-insulin: dissociation of a protein-ligand complex.

Authors:  D L Bakaysa; J Radziuk; H A Havel; M L Brader; S Li; S W Dodd; J M Beals; A H Pekar; D N Brems
Journal:  Protein Sci       Date:  1996-12       Impact factor: 6.725

Review 5.  Insulin Formulation Characterization-the Thioflavin T Assays.

Authors:  Morten Schlein
Journal:  AAPS J       Date:  2016-12-20       Impact factor: 4.009

6.  Chemical and thermal stability of insulin: effects of zinc and ligand binding to the insulin zinc-hexamer.

Authors:  Kasper Huus; Svend Havelund; Helle B Olsen; Marco van de Weert; Sven Frokjaer
Journal:  Pharm Res       Date:  2006-09-13       Impact factor: 4.200

7.  Structural signatures of the complex formed between 3-nitro-4-hydroxybenzoate and the Zn(II)-substituted R(6) insulin hexamer.

Authors:  Helle Birk Olsen; Melissa R Leuenberger-Fisher; Webe Kadima; Dan Borchardt; Niels C Kaarsholm; Michael F Dunn
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

8.  Biophysical optimization of a therapeutic protein by nonstandard mutagenesis: studies of an iodo-insulin derivative.

Authors:  Vijay Pandyarajan; Nelson B Phillips; Gabriela P Cox; Yanwu Yang; Jonathan Whittaker; Faramarz Ismail-Beigi; Michael A Weiss
Journal:  J Biol Chem       Date:  2014-07-03       Impact factor: 5.157

9.  Computational and structural evidence for neurotransmitter-mediated modulation of the oligomeric states of human insulin in storage granules.

Authors:  Vladimír Palivec; Cristina M Viola; Mateusz Kozak; Timothy R Ganderton; Květoslava Křížková; Johan P Turkenburg; Petra Haluŝková; Lenka Žáková; Jiří Jiráĉek; Pavel Jungwirth; Andrzej M Brzozowski
Journal:  J Biol Chem       Date:  2017-03-27       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.